The landscape of ALK alterations in non-small cell lung cancer

被引：0
|
作者：
Desai, A. [1 ]
Mohammed, T. [2 ]
Rakshit, S. [1 ]
Krull, J. [1 ]
机构：
[1] Mayo Clin, Oncol, Rochester, MN USA
[2] Univ Connecticut, Hartford, CT 06112 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21P
引用
收藏
页码：S707 / S707
页数：1
相关论文
共 50 条
  • [41] ALK inhibitors in non-small cell lung cancer: the latest evidence and developments
    Sullivan, Ivana
    Planchard, David
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (01) : 32 - 47
  • [42] Frequency of ALK Translocations in 2560 Non-Small Cell Lung Cancer Samples
    Glassco, J.
    Ha, T.
    Bouman, D.
    Choppa, P.
    Bloom, K. J.
    [J]. MODERN PATHOLOGY, 2012, 25 : 476A - 476A
  • [43] Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer
    Sweis, Randy F.
    Thomas, Sachdev
    Bank, Bruce
    Fishkin, Paul
    Mooney, Colin
    Salgia, Ravi
    [J]. CUREUS, 2016, 8 (02):
  • [44] Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
    Mattsson, Johanna S. M.
    Brunnstrom, Hans
    Jabs, Verena
    Edlund, Karolina
    Jirstrom, Karin
    Mindus, Stephanie
    la Fleur, Linnea
    Ponten, Fredrik
    Karlsson, Mats G.
    Karlsson, Christina
    Koyi, Hirsh
    Branden, Eva
    Botling, Johan
    Helenius, Gisela
    Micke, Patrick
    Svensson, Maria A.
    [J]. BMC CANCER, 2016, 16
  • [45] FREQUENCY OF ALK TRANSLOCATIONS IN 8221 NON-SMALL CELL LUNG CANCER SAMPLES
    Bloom, Kenneth J.
    Choppa, Paul
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S129 - S130
  • [46] Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer
    Bland, Abigail R.
    Bower, Rebekah L.
    Nimick, Mhairi
    Hawkins, Bill C.
    Rosengren, Rhonda J.
    Ashton, John C.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 865
  • [47] Therapeutic strategies in advanced ALK positive non-small cell lung cancer
    Tiotiu, A.
    Billon, Y.
    Vaillant, P.
    Menard, O.
    Hofman, P.
    Mascaux, C.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (10) : 1107 - 1116
  • [48] Future options for ALK-positive non-small cell lung cancer
    Iacono, Daniela
    Chiari, Rita
    Metro, Giulio
    Bennati, Chiara
    Bellezza, Guido
    Cenci, Matteo
    Ricciuti, Biagio
    Sidoni, Angelo
    Baglivo, Sara
    Minotti, Vincenzo
    Crino, Lucio
    [J]. LUNG CANCER, 2015, 87 (03) : 211 - 219
  • [49] Brigatinib as a treatment of ALK-positive non-small cell lung cancer
    De Carlo, Elisa
    Stanzione, Brigida
    Del Conte, Alessandro
    Revelant, Alberto
    Bearz, Alessandra
    [J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (05): : 299 - 305
  • [50] Clinical outcomes of ALK plus non-small cell lung cancer in Denmark
    Hansen, Karin Holmskov
    Johansen, Jakob Sidenius
    Urbanska, Edyta Maria
    Meldgaard, Peter
    Hjorth-Hansen, Peter
    Kristiansen, Charlotte
    Stelmach, Miroslaw
    Santoni-Rugiu, Eric
    Ulhoi, Maiken Parm
    Dydensborg, Anders Bondo
    Dunweber, Christina
    Andersen, Jon Lykkegaard
    [J]. ACTA ONCOLOGICA, 2023, 62 (12) : 1775 - 1783
12345